BBIO
BridgeBio Pharma, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Fund move
Fund move
Last report0 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
+5.97%
vs ±10.2% implied · ×0.58
shaded = implied · ▲▼ = realized
BridgeBio Pharma, Inc.
74.98
+0.03 · +0.04%
post 74.31 −0.90%
No thesis.
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Jupiter TopcoJupiter Topco | $1.1B | 6.83% | — | |
| 2 | Kohlberg Kravis RobertsKohlberg Kravis Roberts | $987.7M | 6.42% | 0.00% | |
| 3 | Farallon Capital ManagementFarallon | $800.1M | 5.20% | +14.71% | |
| 4 | BlackRockBlackRockindex-like | $766.2M | 4.98% | −27.59% | |
| 5 | Viking Global InvestorsViking Global Investors | $741.0M | 4.82% | −15.99% | |
| 6 | Vanguard Capital ManagementVanguardindex-like | $588.3M | 3.83% | +1.80% | |
| 7 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $570.3M | 3.71% | −5.25% | |
| 8 | Jane Street GroupJane Street | $455.3M | 2.96% | +23.87% | |
| 9 | UBS GroupUBS | $420.8M | 2.74% | −4.09% | |
| 10 | Wellington Management GroupWellington | $395.4M | 2.57% | +113.73% | |
| 11 | Two Sigma InvestmentsTwo Sigma | $353.4M | 2.30% | +52.06% | |
| 12 | Aisling Capital ManagementAisling | $341.8M | 2.22% | −9.82% | |
| 13 | State StreetState Streetindex-like | $330.4M | 2.15% | −10.10% | |
| 14 | Citadel AdvisorsCitadel | $322.3M | 2.10% | +27.63% | |
| 15 | Susquehanna International GroupSusquehanna International | $317.2M | 2.06% | +18.07% | |
| 16 | InvescoInvesco | $275.6M | 1.79% | −19.42% | |
| 17 | D. E. ShawD. E. Shaw | $272.9M | 1.77% | +43.94% | |
| 18 | Geode Capital ManagementGeodeindex-like | $254.7M | 1.66% | −30.49% | |
| 19 | JPMorgan ChaseJPMorgan Chase | $173.2M | 1.13% | +82.74% | |
| 20 | Adage Capital Partners GPAdage Capital Partners GP | $167.7M | 1.09% | +275.96% | |
| 21 | Franklin ResourcesFranklin Resources | $160.9M | 1.05% | −11.43% | |
| 22 | Polar Capital HoldingsPolar Capital | $153.7M | 1.00% | −18.09% | |
| 23 | FMRFMR | $153.5M | 1.00% | −12.05% | |
| 24 | Manufacturers Life Insurance Company, theManufacturers Life Insurance Company, the | $145.7M | 0.95% | −1.08% | |
| 25 | Goldman Sachs GroupGoldman Sachs | $139.1M | 0.91% | −4.57% |
480 managers report $15.4B of BridgeBio Pharma on form 13F for the quarter ended Jun 30 '26. 44 of them hold 80% of it; Jupiter Topco is largest at 6.83%.
Expected move
Inputsspot 75.00exp Jan 15ATM strike 75ATM straddle 12.10IV 45%